Press release
Spatial Genomics & Transcriptomics Market worth $1,913.12 million by 2030, growing at a CAGR of 13.62% - Exclusive Report by 360iResearch
Spatial Genomics & Transcriptomics Market | 360iResearch
The Global Spatial Genomics & Transcriptomics Market to grow from USD 782.33 million in 2023 to USD 1,913.12 million by 2030, at a CAGR of 13.62%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/spatial-genomics-transcriptomics?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Spatial genomics & transcriptomics is a technique that allows users to obtain gene expression information in a spatial context. This technique has become vital for biomedical research, particularly in developmental biology, cancer, immunology, and neuroscience, to design more effective therapeutics. The rising popularity of spatial analysis in precision medicine has also brought the regulatory and ethical acceptance of genomics and sequencing technologies. However, limited awareness of genomic medicine in developing economies and a shortage of trained medical professionals limit the expansion of spatial techniques. Reimbursement inconsistency and uncertainty in gene & single-cell sequencing are also restraining factors for the market development. Technological advancements in spatial biology primarily focused on artificial intelligence (AI), 3D printing, and standardized diagnostic biomarkers have emerged as a boon for fighting these challenges for the use of spatial genomics and transcriptomics. In the coming years, rising public and private funding for genomics & transcriptomics research is also expected to diversify the use of these technologies in healthcare and life science.
The Americas has a strong and growing spatial genomics and transcriptomics market, driven by the presence of well-recognized healthcare startups and immense investments for diversifying the product's R&D portfolio. In October 2022, the Government of Canada announced an investment of over USD 5.6 million for Ontario Genomics to deliver the BioCreate program for helping genomics SMEs in the health, food, and agriculture, and cleantech sectors to bring new products and technologies to market. In the Asia-Pacific region, spatial analysis is used in regenerative medicine drug development scenarios funded by government and biopharma companies. The country's increased disease burden has been the pillar for the increasing shift to advanced technologies such as spatial genomics and transcriptomics. Owing to the increased concerns associated with ethical acceptance, the use of spatial genomics and transcriptomics is expected to be highly regulated in the Middle East and Africa region. European governments are at the forefront of promoting spatial analysis with government-backed projects introducing new supportive technologies and the rising shift to precision medicine across the economies.
Market Segmentation & Coverage:
This research report categorizes the Spatial Genomics & Transcriptomics Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Product, market is studied across Consumables, Instruments, and Software. The Software is projected to witness significant market share during forecast period.
Based on Technology, market is studied across Immunohistochemistry Screening, Spatial Genomics, and Spatial Transcriptomics. The Spatial Genomics is further studied across Biochemical Techniques, Fluorescence in Situ Hybridization, Genome Perturbation Tools, Massively-Parallel Sequencing, and Microscopy-Based Live DNA Imaging. The Spatial Transcriptomics is further studied across In Situ Sequencing, Microtomy Sequencing, Sequencing-Based Methods, and Transcriptome In-vivo Analysis. The Spatial Transcriptomics is projected to witness significant market share during forecast period.
Based on End-Use, market is studied across Academic Institutes, Diagnostic Institutes, Pharmaceutical Manufacturer, and Translational Research. The Diagnostic Institutes is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/spatial-genomics-transcriptomics?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Spatial Genomics & Transcriptomics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Spatial Genomics & Transcriptomics Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Spatial Genomics & Transcriptomics Market, highlighting leading vendors and their innovative profiles. These include 10X Genomics, Inc., Akoya Biosciences, Inc., Arima Genomics, Inc., AtlasXomics Inc., Axcelead Drug Discovery Partners Inc., BGI Australia, Bio-Techne Corporation, BioSpyder Technologies Inc., Bruker Corporation, Bucher Biotec AG, CD Genomics, CeGaT GmbH, Dovetail Genomics, LLC, Easi-Genomics, Enzo Life Sciences, Inc., Eurofins Genomics, Fulgent Genetics, Genomic Vision SA, Illumina, Inc., Indivumed Group, Ionpath, Inc., Lunaphore Technologies S.A., Miltenyi Biotec, Nanostring Technologies, Inc., Natera Inc., Novogene Co, Ltd., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., PT Pandu Biosains, Rarecyte, Inc, Rebus Biosystems, Inc., Resolve Biosciences GmbH, S2 Genomics, Inc., Seven Bridges Genomics, Single Cell Discoveries, Single Technologies AB, Singular Genomics System, Inc., Spatial Genomics, Springer Nature, Standard BioTools Inc., Tecan Group Ltd., Ultivue, Inc., Veracyte, Inc., Veranome Biosystems, LLC, and Vizgen Corporation.
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Spatial Genomics & Transcriptomics Market, by Product
7. Spatial Genomics & Transcriptomics Market, by Technology
8. Spatial Genomics & Transcriptomics Market, by End-Use
9. Americas Spatial Genomics & Transcriptomics Market
10. Asia-Pacific Spatial Genomics & Transcriptomics Market
11. Europe, Middle East & Africa Spatial Genomics & Transcriptomics Market
12. Competitive Landscape
13. Competitive Portfolio
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Spatial Genomics & Transcriptomics Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Spatial Genomics & Transcriptomics Market?
3. What is the competitive strategic window for opportunities in the Spatial Genomics & Transcriptomics Market?
4. What are the technology trends and regulatory frameworks in the Spatial Genomics & Transcriptomics Market?
5. What is the market share of the leading vendors in the Spatial Genomics & Transcriptomics Market?
6. What modes and strategic moves are considered suitable for entering the Spatial Genomics & Transcriptomics Market?
Read More @ https://www.360iresearch.com/library/intelligence/spatial-genomics-transcriptomics?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Spatial Genomics & Transcriptomics Market worth $1,913.12 million by 2030, growing at a CAGR of 13.62% - Exclusive Report by 360iResearch here
News-ID: 3437405 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Genomic
Emerging Trends Influencing The Growth Of The Genomic Biomarker Market: Technolo …
The Genomic Biomarker Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Genomic Biomarker Market Size Expected to Be by 2034?
The size of the genomic biomarker market has witnessed swift expansion in the recent past. It is slated to expand from a…
Top Factor Driving Genomic Biomarker Market Growth in 2025: Impact of Chronic Di …
How Big Is the Genomic Biomarker Market Expected to Be, and What Will Its Growth Rate Be?
The size of the genomic biomarker market has seen a swift expansion in recent times. It's expected to increase from $8.4 billion in 2024 to $9.9 billion in 2025, growing at a compound annual growth rate (CAGR) of 18.0%. The historic period growth can be credited to the growing awareness about genetic disorders, heightened…
Genomic Biomarker Market Future Business Opportunities 2025-2032 | Liquid Genomi …
Latest Report, titled "Genomic Biomarker Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Genomic Biomarker market has been expanding significantly…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
Genomic Biomarkers Market 2022 | Detailed Report
The research reports on “Genomic Biomarkers Market” report gives detailed overview of factors that affect global business scope. Genomic Biomarkers Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5334064
The…
Latest Survey on Genomic Medicine Market 2019 by Key Companies Overview-BioMed C …
The recently published report called “Global Genomic Medicine Market 2019” offers a brief overview of the Genomic Medicine market across the globe. The research report showcases innovative tool for evaluating the complete scenario of the Genomic Medicine market with its tactical decision making, opportunities and supporting strategic. Furthermore, the report also analyses the competitive analysis as well as changing trends which becomes most crucial in order to monitor the performance…
